PTH, vitamin D, and the FGF‐23–klotho axis and heart: Going beyond the confines of nephrology

PTH, vitamin D, and the FGF‐23–klotho axis and heart: Going beyond the confines of nephrology INTRODUCTIONPhosphate homoeostasis is maintained by a counterbalance between dietary phosphate absorption by the intestine, mobilization from bone, and renal excretion: the so‐called bone–kidney endocrine axis. Endocrine factors, including the classical mineral metabolism components, vitamin D and parathyroid hormone (PTH), and also the newer nonclassical mineral metabolism components, fibroblast growth factor (FGF)‐23 and its co‐receptor klotho, are intimately involved in the control of systemic phosphate homoeostasis. Alterations in these components have been traditionally circumscribed to patients with renal disease; however, in the last decades, a large number of clinical and basic/experimental studies have provided evidence that abnormalities in these mineral components can also trigger important and even independent cardiotoxic effects. Accordingly, it is now known that changes to the levels of these systemic mineral components increase, directly and indirectly, cardiovascular (CV) risk in patients with chronic kidney disease (CKD). Beyond the nephropathological context, these changes are also independently associated with clinical cardiac disease and its complications, including left ventricular hypertrophy (LVH), heart failure (HF) and atrial fibrillation (AF), among others. For instance, a deficiency in vitamin D is considered a predictor of reduced survival in patients with HF. Similarly, several recent prospective trials and meta‐analyses have shown that supraphysiological circulating http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

PTH, vitamin D, and the FGF‐23–klotho axis and heart: Going beyond the confines of nephrology

Loading next page...
 
/lp/wiley/pth-vitamin-d-and-the-fgf-23-klotho-axis-and-heart-going-beyond-the-YwmG5p2obT
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
D.O.I.
10.1111/eci.12902
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONPhosphate homoeostasis is maintained by a counterbalance between dietary phosphate absorption by the intestine, mobilization from bone, and renal excretion: the so‐called bone–kidney endocrine axis. Endocrine factors, including the classical mineral metabolism components, vitamin D and parathyroid hormone (PTH), and also the newer nonclassical mineral metabolism components, fibroblast growth factor (FGF)‐23 and its co‐receptor klotho, are intimately involved in the control of systemic phosphate homoeostasis. Alterations in these components have been traditionally circumscribed to patients with renal disease; however, in the last decades, a large number of clinical and basic/experimental studies have provided evidence that abnormalities in these mineral components can also trigger important and even independent cardiotoxic effects. Accordingly, it is now known that changes to the levels of these systemic mineral components increase, directly and indirectly, cardiovascular (CV) risk in patients with chronic kidney disease (CKD). Beyond the nephropathological context, these changes are also independently associated with clinical cardiac disease and its complications, including left ventricular hypertrophy (LVH), heart failure (HF) and atrial fibrillation (AF), among others. For instance, a deficiency in vitamin D is considered a predictor of reduced survival in patients with HF. Similarly, several recent prospective trials and meta‐analyses have shown that supraphysiological circulating

Journal

European Journal of Clinical InvestigationWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial